Effect of Continuing Versus Holding Metformin During Hospitalizations.

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Illinois at Chicago
Study ID
NCT06296836
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 110 Years
Healthy Volunteers
Not accepted

Interventions

  • Metformin — DRUG
    Continuation of home metformin

Study Details

A randomized study of continuing versus holding metformin during hospitalizations to internal medicine services to determine the effects on glucose control, acidosis, abdominal symptoms, length of stay, and mortality.

Key Dates

Start date
Jan 21, 2025
Status verified
Feb 2025
Primary completion
Mar 31, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
300 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Metformin continuation
    Continuation of home metformin regimen during hospitalization to an internal medicine service
  • No Intervention: Metformin discontinuation
    Holding home metformin regimen during hospitalization to an internal medicine service

Primary Outcome Measure

Mean glucose levels [ Time Frame: During hospitalization ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Illinois at ChicagoChicagoIllinois60612
Mathew M Thambi, PharmD, MPH
[email protected]

Find similar trials in Chicago, IL

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
University of Illinois at Chicago· Chicago, IL

Related Studies